Levothyroxine Sodium Tablet
Product Images NDC 51655-714

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-714). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 714 52 Master Bottle Label Approval Rev A 05 21)

Label (51655 714 52 Master Bottle Label Approval   Rev A 05 21)
Label for levothyroxine sodium 175 mcg oral tablets by Northwind Health Company, LLC. The label indicates this is a 30-tablet prescription package, with storage instructions and warnings about dosage and excursions.*
FDA Label Image

Levothyroxine-structure (Structure)

Levothyroxine-structure (Structure)
Chemical structure of levothyroxine sodium, showing two iodinated aromatic rings connected via an oxygen atom, with a side chain containing an amino group (NH2), a carboxylate group (COONa), and a variable number of water molecules (xH2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.